KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    ROLE OF BILE ACIDS AND FARNESOID X RECEPTOR IN HEPATIC AUTOPHAGY AND ITS IMPLICATIONS IN ETHANOL-INDUCED HEPATOTOXICITY

    Thumbnail
    View/Open
    Manley_ku_0099D_13717_DATA_1.pdf (7.357Mb)
    Issue Date
    2014-12-31
    Author
    Manley, Sharon
    Publisher
    University of Kansas
    Format
    235 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Pharmacology, Toxicology & Therapeutics
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Retention of bile acids (BAs) in the liver during cholestasis plays an important role in the development of cholestatic liver injury. Several studies have reported that high concentrations of certain BAs induce cell death and inflammatory response in the liver, and BAs may promote liver tumorigenesis. Macroautophagy (hereafter referred to as autophagy) is a lysosomal degradation process that regulates organelle and protein homeostasis and serves as a cell survival mechanism under a variety of stress conditions. However, it is not known if BAs modulate autophagy in hepatocytes. In the present study, we determined autophagic flux in livers of farnesoid X receptor (FXR) knockout (KO) mice that have increased concentrations of hepatic BAs and in primary cultured mouse hepatocytes that were treated with BAs. The results showed that autophagic flux was impaired in livers of FXR KO mice and in BA-treated primary mouse hepatocytes. Mechanistically, BAs did not affect the activities of cathepsin or the proteasome, but impaired autophagosomal-lysosomal fusion likely due to reduction of Rab7 protein expression and targeting to autophagosomes. In conclusion, BAs suppress autophagic flux in hepatocytes by impairing autophagosomal-lysosomal fusion, which may be implicated in bile acid-induced liver tumor promotion observed in FXR KO mice. Alcoholic liver disease encompasses a wide spectrum of pathogenesis including steatosis, fibrosis, cirrhosis, and alcoholic steatohepatitis. Acute alcohol treatment induces autophagy via FoxO3a-mediated autophagy related gene expression and protects against alcohol-induced steatosis and liver injury in mice. Moreover, inhibition of autophagy by pharmacological approach or deletion of autophagy genes exacerbates alcohol-induced steatosis and hepatotoxicity. Because we found that FXR KO mice had impaired hepatic autophagy and the role of FXR in ethanol hepatotoxicity is not known, we thus determined the hepatotoxicity and its mechanisms induced by acute ethanol treatment in FXR KO mice. In the present study, wild type and FXR KO mice were treated with acute ethanol for 16 hours. We found that ethanol treated-FXR KO mice had exacerbated hepatotoxicity and steatosis compared to wild type mice. Furthermore, we found that ethanol treatment had decreased expression of various essential autophagy genes and several other FoxO3a target genes in FXR KO mice compared with wild type mice. Mechanistically, we did not find a direct interaction between FXR and FoxO3a. Ethanol-treated FXR KO mice had increased Akt activation, increased phosphorylation of FoxO3a resulting in decreased FoxO3a nuclear retention and DNA binding. Furthermore, ethanol treatment induced hepatic mitochondrial spheroid formation in FXR KO mice, but not in wild type mice, which may serve as a compensatory alternative pathway to remove ethanol-induced damaged mitochondria in FXR KO mice. Moreover, induction of FXR with WAY-362450 protected against acute ethanol-induced steatosis, but not hepatotoxicity. These results suggest that lack of FXR impaired FoxO3a-mediated autophagy and in turn exacerbated alcohol-induced liver injury. In conclusion, this dissertation provided novel insights in how two different liver pathologies may cross talk. We demonstrated that the increased hepatic bile acid levels lead to impaired autophagy through the inhibition of autophagosomal-lysosomal fusion. Moreover, FXR deficiency exacerbated alcohol induced hepatotoxicity and steatosis likely by two mechanisms: bile acid-mediated inhibition of autophagy and Akt-mediated repression of ethanol-induced FoxO3a activation. This dissertation presented novel therapeutic targets for both cholestasic liver injury and alcoholic liver disease. Autophagy and FXR are possible therapeutic targets for cholestasis, whereas, FXR and FoxO3a emerge as novel therapeutic targets for alcoholic liver disease.
    URI
    http://hdl.handle.net/1808/18425
    Collections
    • Dissertations [4625]
    • Pharmacy Dissertations and Theses [118]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    Login

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps